Scientist on Stocks
Special situations, value, long/short equity, biotech

Reckitt Benckiser Sues BioDelivery Sciences And Creates A Short Opportunity

At the time of writing this article, I checked BioDelivery International Inc. (NASDAQ:BDSI) website and its latest SEC filings for any news related to the fact that Reckitt Benckiser Pharmaceuticals (RBP) has sued BDSI for filing a New Drug Application for BUNAVAIL, a lead product in BDSI's pipeline. I am surprised why BDSI has not informed their investors regarding this material event. With this new litigation, BDSI shares may put off some of the gains that were priced in over past several months in anticipation of a timely approval and/or securing a partner for BUNAVAIL.

  • Background:

About RBP: It's a part of ~$46B Reckitt Benckiser Group Plc (OTC:RBGPY), a manufacturer and marketer of branded products in...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details